Griffin Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Buy
110,155
+182
+0.2% +$21.3K 1.49% 21
2026
Q1
$13.2M Sell
109,973
-3,133
-3% -$362K 1.49% 23
2025
Q4
$11.9M Buy
113,106
+6,657
+6% +$625K 1.29% 24
2025
Q3
$8.93M Sell
106,449
-572
-0.5% -$47.1K 1% 34
2025
Q2
$8.47M Sell
107,021
-1,345
-1% -$107K 1% 35
2025
Q1
$9.73M Buy
108,366
+423
+0.4% +$39.5K 1.19% 26
2024
Q4
$10.7M Sell
107,943
-2,868
-3% -$296K 1.26% 23
2024
Q3
$12.6M Buy
110,811
+1,243
+1% +$148K 1.41% 17
2024
Q2
$13.6M Sell
109,568
-956
-0.9% -$123K 1.57% 12
2024
Q1
$14.6M Sell
110,524
-366
-0.3% -$45.1K 1.74% 9
2023
Q4
$12.1M Buy
110,890
+1,792
+2% +$186K 1.53% 10
2023
Q3
$11.2M Sell
109,098
-4,572
-4% -$493K 1.6% 10
2023
Q2
$13.1M Sell
113,670
-6,194
-5% -$703K 1.78% 6
2023
Q1
$12.8M Sell
119,864
-1,589
-1% -$172K 1.78% 7
2022
Q4
$13.5M Sell
121,453
-5,424
-4% -$554K 2.03% 6
2022
Q3
$10.9M Buy
126,877
+28
+0% +$2.5K 1.82% 8
2022
Q2
$11.6M Buy
126,849
+3,127
+3% +$277K 1.85% 7
2022
Q1
$10.2M Buy
123,722
+21,390
+21% +$1.69M 1.32% 15
2021
Q4
$7.84M Buy
102,332
+2,145
+2% +$171K 0.97% 27
2021
Q3
$7.53M Sell
100,187
-18,239
-15% -$1.39M 0.96% 29
2021
Q2
$9.21M Sell
118,426
-4,399
-4% -$327K 1.11% 22
2021
Q1
$9.04M Buy
122,825
+2,451
+2% +$181K 1.16% 19
2020
Q4
$9.4M Buy
120,374
+11,620
+11% +$889K 1.25% 15
2020
Q3
$8.61M Sell
108,754
-19,417
-15% -$1.52M 1.32% 13
2020
Q2
$9.46M Buy
128,171
+1,976
+2% +$149K 1.51% 12
2020
Q1
$9.27M Buy
126,195
+9,688
+8% +$761K 1.75% 8
2019
Q4
$10.1M Sell
116,507
-1,256
-1% -$103K 1.42% 10
2019
Q3
$9.46M Sell
117,763
-1,018
-0.9% -$81.6K 1.47% 9
2019
Q2
$9.5M Sell
118,781
-3,847
-3% -$295K 1.21% 14
2019
Q1
$9.73M Sell
122,628
-6,592
-5% -$493K 1.38% 13
2018
Q4
$9.42M Sell
129,220
-230
-0.2% -$16.2K 1.59% 11
2018
Q3
$8.76M Buy
129,450
+4,445
+4% +$283K 1.29% 15
2018
Q2
$7.24M Sell
125,005
-271
-0.2% -$15.3K 1.31% 19
2018
Q1
$6.51M Buy
125,276
+3,917
+3% +$212K 1.19% 25
2017
Q4
$6.52M Sell
121,359
-1,999
-2% -$111K 1.16% 26
2017
Q3
$7.54M Buy
123,358
+10,278
+9% +$623K 1.36% 17
2017
Q2
$6.92M Buy
+113,080
New +$6.88M 1.85% 14
2015
Q4
$6.33M Sell
125,701
-4,033
-3% -$203K 2.66% 11
2015
Q3
$6.11M Sell
129,734
-4,208
-3% -$224K 2.54% 10
2015
Q2
$7.28M Sell
133,942
-10,854
-7% -$609K 2.79% 8
2015
Q1
$7.94M Sell
144,796
-2,332
-2% -$132K 2.31% 10
2014
Q4
$7.97M Sell
147,128
-2,697
-2% -$150K 2.12% 13
2014
Q3
$8.47M Buy
149,825
+13,472
+10% +$756K 2.53% 7
2014
Q2
$7.53M Buy
136,353
+3,906
+3% +$213K 2.35% 9
2014
Q1
$7.17M Sell
132,447
-22,692
-15% -$1.18M 2.33% 12
2013
Q4
$7.41M Buy
155,139
+369
+0.2% +$16.9K 2.39% 10
2013
Q3
$7.03M Sell
154,770
-3,352
-2% -$153K 2.3% 11
2013
Q2
$7.01M Buy
+158,122
New +$7.06M 2.54% 10

Other funds holding MRK

Griffin Asset Management's MRK Position: Q2 2026 in Review

Griffin Asset Management increased its Merck (MRK) stake by 0.17% in Q2 2026, buying an estimated $21.3K and bringing the position to 110,155 shares worth $14.2M. The position accounts for 1.49% of the portfolio, ranked #21.

Griffin Asset Management first reported a position in MRK in Q2 2013 and has held it in 48 quarters since. The position peaked at $14.6M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Griffin Asset Management held 110,155 shares of Merck worth $14.2M as of Q2 2026.
  • Griffin Asset Management bought 182 Merck shares in Q2 2026, an estimated $21.3K.
  • Merck made up 1.49% of Griffin Asset Management's portfolio in Q2 2026, its #21 holding.
  • Griffin Asset Management first reported a position in Merck in Q2 2013 and has held it in 48 quarters since.
  • Griffin Asset Management's Merck position peaked at $14.6M in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Griffin Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.